Search
Search
Journalism from the heart of crises
  1. Home
  2. Southern Africa
  3. Botswana

Still no guidelines for generic AIDS drugs

    JOHANNESBURG
    International health officials attending a conference in Botswana had failed to reach an agreement on global guidelines for low-cost generic HIV/AIDS drugs after US officials raised concerns about their safety, the Associated Press news agency reported. The World Health Organisation (WHO) said fixed-dose combination drugs containing three medicines in one pill were considerably cheaper than their patented equivalents and a key part of its plan to treat 3 million people in developing countries by 2005. However, US officials questioned whether WHO's screening process was stringent enough, and expressed concern that widespread, inappropriate distribution of the drugs could lead to drug resistance. Organisers of the Conference on Fixed-Dose Combination Drug Products plan to publish their deliberations for comment by 19 April.

    This article was produced by IRIN News while it was part of the United Nations Office for the Coordination of Humanitarian Affairs. Please send queries on copyright or liability to the UN. For more information: https://shop.un.org/rights-permissions

    Share this article

    Get the day’s top headlines in your inbox every morning

    Starting at just $5 a month, you can become a member of The New Humanitarian and receive our premium newsletter, DAWNS Digest.

    DAWNS Digest has been the trusted essential morning read for global aid and foreign policy professionals for more than 10 years.

    Government, media, global governance organisations, NGOs, academics, and more subscribe to DAWNS to receive the day’s top global headlines of news and analysis in their inboxes every weekday morning.

    It’s the perfect way to start your day.

    Become a member of The New Humanitarian today and you’ll automatically be subscribed to DAWNS Digest – free of charge.

    Become a member of The New Humanitarian

    Support our journalism and become more involved in our community. Help us deliver informative, accessible, independent journalism that you can trust and provides accountability to the millions of people affected by crises worldwide.

    Join